NCT07563036Recruiting
JAK2 Expression in Androgenetic Alopecia Before and After Topical Minoxidil
Assessment of Janus Kinase 2 Expression in Patients With Androgenic Alopecia and Its Modulation by Topical Minoxidil Therapy.
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Recruiting
- Declared phase
- Not applicable (NA in the registry)
- Sponsor
- Kasr El Aini Hospital
- Participants (registry)
- 25
- Start
- February 2026
- Primary completion
- October 2026
- Study completion
- January 2027 (planned)
- Last registry update
- May 2026
- Countries
- Egypt
Conditions studied: Androgenetic Alopecia, Androgenic Alopecia
Interventions: Topical Minoxidil 5% Solution, Scalp Punch Biopsy, Tissue JAK2 Protein Measurement by ELISA
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.